182 related articles for article (PubMed ID: 7788922)
1. Angiotensin II type 1 receptor blockade inhibits the expression of immediate-early genes and fibronectin in rat injured artery.
Kim S; Kawamura M; Wanibuchi H; Ohta K; Hamaguchi A; Omura T; Yukimura T; Miura K; Iwao H
Circulation; 1995 Jul; 92(1):88-95. PubMed ID: 7788922
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin II type I receptor antagonist inhibits the gene expression of transforming growth factor-beta 1 and extracellular matrix in cardiac and vascular tissues of hypertensive rats.
Kim S; Ohta K; Hamaguchi A; Omura T; Yukimura T; Miura K; Inada Y; Ishimura Y; Chatani F; Iwao H
J Pharmacol Exp Ther; 1995 Apr; 273(1):509-15. PubMed ID: 7714806
[TBL] [Abstract][Full Text] [Related]
3. Involvement of angiotensin II in cardiovascular and renal injury: effects of an AT1-receptor antagonist on gene expression and the cellular phenotype.
Kim S; Iwao H
J Hypertens Suppl; 1997 Dec; 15(6):S3-7. PubMed ID: 9493120
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin II type 1 receptor blockade prevents up-regulation of angiotensin II type 1A receptors in rat injured artery.
Tazawa S; Nakane T; Chiba S
J Pharmacol Exp Ther; 1999 Feb; 288(2):898-904. PubMed ID: 9918604
[TBL] [Abstract][Full Text] [Related]
5. Stimulated activation of platelet-derived growth factor receptor in vivo in balloon-injured arteries: a link between angiotensin II and intimal thickening.
Abe J; Deguchi J; Matsumoto T; Takuwa N; Noda M; Ohno M; Makuuchi M; Kurokawa K; Takuwa Y
Circulation; 1997 Sep; 96(6):1906-13. PubMed ID: 9323080
[TBL] [Abstract][Full Text] [Related]
6. TCV-116, a novel angiotensin II receptor antagonist, prevents intimal thickening and impairment of vascular function after carotid injury in rats.
Kawamura M; Terashita Z; Okuda H; Imura Y; Shino A; Nakao M; Nishikawa K
J Pharmacol Exp Ther; 1993 Sep; 266(3):1664-9. PubMed ID: 8371164
[TBL] [Abstract][Full Text] [Related]
7. Contribution of renal angiotensin II type I receptor to gene expressions in hypertension-induced renal injury.
Kim S; Ohta K; Hamaguchi A; Omura T; Yukimura T; Miura K; Inada Y; Wada T; Ishimura Y; Chatani F
Kidney Int; 1994 Nov; 46(5):1346-58. PubMed ID: 7853793
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor beta 1 and extracellular matrix gene expression in isoprenaline induced cardiac hypertrophy: effects of inhibition of the renin-angiotensin system.
Omura T; Kim S; Takeuchi K; Iwao H; Takeda T
Cardiovasc Res; 1994 Dec; 28(12):1835-42. PubMed ID: 7867037
[TBL] [Abstract][Full Text] [Related]
9. Inhibition by angiotensin II type 1 receptor antagonist of cardiac phenotypic modulation after myocardial infarction.
Hanatani A; Yoshiyama M; Kim S; Omura T; Toda I; Akioka K; Teragaki M; Takeuchi K; Iwao H; Takeda T
J Mol Cell Cardiol; 1995 Sep; 27(9):1905-14. PubMed ID: 8523451
[TBL] [Abstract][Full Text] [Related]
10. Effects of TH-142177 on angiotensin II-induced proliferation, migration and intracellular signaling in vascular smooth muscle cells and on neointimal thickening after balloon injury.
Nozawa Y; Matsuura N; Miyake H; Yamada S; Kimura R
Life Sci; 1999; 64(22):2061-70. PubMed ID: 10374931
[TBL] [Abstract][Full Text] [Related]
11. [Role of the renin-angiotensin system in cardiovascular and renal diseases].
Kim S
Nihon Yakurigaku Zasshi; 1997 May; 109(5):223-33. PubMed ID: 9211448
[TBL] [Abstract][Full Text] [Related]
12. Role of angiotensin II in renal injury of deoxycorticosterone acetate-salt hypertensive rats.
Kim S; Ohta K; Hamaguchi A; Omura T; Yukimura T; Miura K; Inada Y; Wada T; Ishimura Y; Chatani F
Hypertension; 1994 Aug; 24(2):195-204. PubMed ID: 8039844
[TBL] [Abstract][Full Text] [Related]
13. Losartan, a nonpeptide angiotensin II (Ang II) receptor antagonist, inhibits neointima formation following balloon injury to rat carotid arteries.
Kauffman RF; Bean JS; Zimmerman KM; Brown RF; Steinberg MI
Life Sci; 1991; 49(25):PL223-8. PubMed ID: 1745100
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin II receptor antagonist TCV-116 induces regression of hypertensive left ventricular hypertrophy in vivo and inhibits the intracellular signaling pathway of stretch-mediated cardiomyocyte hypertrophy in vitro.
Kojima M; Shiojima I; Yamazaki T; Komuro I; Zou Z; Wang Y; Mizuno T; Ueki K; Tobe K; Kadowaki T
Circulation; 1994 May; 89(5):2204-11. PubMed ID: 8181146
[TBL] [Abstract][Full Text] [Related]
15. Mithramycin inhibits myointimal proliferation after balloon injury of the rat carotid artery in vivo.
Chen SJ; Chen YF; Miller DM; Li H; Oparil S
Circulation; 1994 Nov; 90(5):2468-73. PubMed ID: 7955204
[TBL] [Abstract][Full Text] [Related]
16. Renal protective effect of TCV-116 in stroke-prone spontaneously hypertensive rats.
Kim S; Ohta K; Hamaguchi A; Omura T; Yukimura T; Miura K; Inada Y; Wada T; Ishimura Y; Chatani F
Blood Press Suppl; 1994; 5():54-6. PubMed ID: 7889201
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin II type 1 receptor antagonist, TCV-116, prevents neointima formation in injured arteries in the dog.
Miyazaki M; Shiota N; Sakonjo H; Takai S
Jpn J Pharmacol; 1999 Apr; 79(4):455-60. PubMed ID: 10361885
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of protein tyrosine kinases attenuates increases in expression of transforming growth factor-beta isoforms and their receptors following arterial injury.
Ward MR; Agrotis A; Kanellakis P; Dilley R; Jennings G; Bobik A
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2461-70. PubMed ID: 9409216
[TBL] [Abstract][Full Text] [Related]
19. Effect of an angiotensin II receptor antagonist, TCV-116, on neointimal formation following balloon injury in the SHR carotid artery.
Kino H; Hama J; Takenaka T; Sugimura K; Kamoi K; Shimada S; Yamamoto Y; Nagata S; Kai T; Horiuchi M
Clin Exp Pharmacol Physiol Suppl; 1995 Dec; 22(1):S360-2. PubMed ID: 9072428
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo effects of UP 269-6, a new potent orally active nonpeptide angiotensin II receptor antagonist, on vascular smooth muscle cell proliferation.
Virone-Oddos A; Desangle V; Provost D; Cazes M; Caussade F; Cloarec A
Br J Pharmacol; 1997 Feb; 120(3):488-94. PubMed ID: 9031754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
